1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Local Public Health Infrastructure Grant Program 2027 is sponsored by New Jersey Department of Health. This program, offered by the New Jersey Department of Health, aims to strengthen public health infrastructure across three Centers for Disease Control and Prevention (CDC) Public Health Infrastructure Grant (PHIG) strategies: Workforce, Foundational Capabilities, and Data Modern…
Get alerted about grants like this
Save a search for “New Jersey Department of Health” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Local Public Health Infrastructure Grant Program • New Jersey League of Municipalities Local Public Health Infrastructure Grant Program Local Public Health Infrastructure Grant Program The New Jersey Department of Health (DOH), through its Division of Local Public Health, has announced the availability of funding under the Local Public Health Infrastructure Grant Program 2027 .
The program supports strengthening public health infrastructure across three Centers for Disease Control and Prevention (CDC) Public Health Infrastructure Grant (PHIG) strategies: Workforce, Foundational Capabilities, and Data Modernization. The grant program is intended to help local health departments build, promote, and protect public health systems and services throughout the state. Approximately $10.
3 million in funding is available for the award period of July 1, 2026, through November 30, 2027. Eligible applicants include local health departments listed in the May 8, 2026, Redbook Directory of Local Health Departments in New Jersey . Both LINCS Agency Local Health Departments and non-LINCS Local Health Departments are eligible to apply.
Applicants must submit a Letter of Intent to the Division of Local Public Health by 3:00 p. m. on May 26, 2026.
Applications will be available on SAGE beginning June 1, 2026, and completed applications are due by June 22, 2026. Additional grant requirements and application procedures are available through DOH. To learn more about the Local Public Health Infrastructure Grant Program, visit the New Jersey Department of Health grants page or contact Paula Van Clef, Research Scientist I, at Paula.
VanClef@doh. nj. gov or 609-376-8699.
Contact : Ciara Bradley, Research Associate, cbradley@njlm. org , 609-695-3481, x128. Grant for Fire Staffing & Volunteer Recruitment Childhood Lead Program Grant Funding Available Funding Available for Regional Planning Grants Funding for Shore Protection Program Grant Program Volunteer Emergency Service Organizations Loan Program Government Websites by CivicPlus®
Based on current listing details, eligibility includes: Local health departments listed in the May 8, 2026, Redbook Directory of Local Health Departments in New Jersey. Both LINCS Agency Local Health Departments and non-LINCS Local Health Departments are eligible. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Funding amounts vary based on project scope and sponsor guidance. Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is June 22, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.